Research progress in the treatment of small cell lung cancer.

J Cancer · 2017 · PMC5264037 · PMID 28123595

Europe PMC DOI

hedged sentence

0.0851

closest p · 1.7× alpha

0.0851

boldest claim

The sentences

showed a trendP =0.0851so close (0.05 < p ≤ 0.1)

However, in the subgroup of analysis among vaccinated patients (n=55), the median survival of humoral responders showed a trend of improvement compared with non-responders (19.2 vs. 13.9 months; P =0.0851). 83 A study of 29 patients who had received p53 vaccine combined with chemotherapy treatments in ED-SCLC showed a high ORR.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.